Reduced CD62L expression on RA PB CD3+ and CD19+ lymphocytes, monocytes and granulocytes [68] has been linked to immunosuppressive therapies including methotrexate [69], and a similar mechanism could explain our observations. Here, CD19 is linked to rheumatoid arthritis.